Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.

scientific article

Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/MNFR.200700331
P698PubMed publication ID18435490
P5875ResearchGate publication ID5418359

P50authorDiego ArangoQ38642741
John M MariadasonQ60960610
P2093author name stringChang Tong
Leonard H Augenlicht
Wancai Yang
Min Zhuang
Maomi Li
Tianhong Li
Do-Sun Byun
Shannon Nasser
P2860cites workBiphasic increase of apical Cl− conductance by muscarinic stimulation of ht-29cl.19a human colon carcinoma cell line: Evidence for activation of different cl− conductances by carbachol and forskolinQ41633293
A mucus-secreting human colonic cancer cell line. Purification and partial characterization of the secreted mucinsQ42835780
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectcolorectal cancerQ188874
P304page(s)1289-1299
P577publication date2008-11-01
P1433published inMolecular Nutrition and Food ResearchQ15751861
P1476titleExpression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer
P478volume52

Reverse relations

cites work (P2860)
Q90310127A Caenorhabditis elegans ortholog of human selenium-binding protein 1 is a pro-aging factor protecting against selenite toxicity
Q36324749A Critical Role for Cysteine 57 in the Biological Functions of Selenium Binding Protein-1.
Q37597313A sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis
Q41170872ATF3 suppresses ESCC via downregulation of ID1.
Q84245713Altered expression of selenium-binding protein 1 in gastric carcinoma and precursor lesions
Q28541543Applying of hierarchical clustering to analysis of protein patterns in the human cancer-associated liver
Q34193882Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity
Q34250582Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma
Q35997645Distribution and inhibition effect of Seleno-L-Methionine on 4T1 mouse mammary carcinoma
Q41493120Does aberrant membrane transport contribute to poor outcome in adult acute myeloid leukemia?
Q35069680Downregulation of cellular protective factors of rumen epithelium in goats fed high energy diet
Q35067875EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
Q34000677Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells
Q28547310Evidence that selenium binding protein 1 is a tumor suppressor in prostate cancer
Q34042351Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein
Q24313015Human selenium binding protein-1 (hSP56) interacts with VDU1 in a selenium-dependent manner
Q38990401Human selenium binding protein-1 (hSP56) is a negative regulator of HIF-1α and suppresses the malignant characteristics of prostate cancer cells
Q42032848Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition
Q34571042Identification of novel biomarkers for sepsis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS.
Q42632704Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue
Q38097279Is selenium a potential treatment for cancer metastasis?
Q36073942Loss of Selenium-Binding Protein 1 Decreases Sensitivity to Clastogens and Intracellular Selenium Content in HeLa Cells
Q27011247Molecular cross-talk between members of distinct families of selenium containing proteins
Q37392350Molecular mechanisms by which selenoproteins affect cancer risk and progression
Q34618992Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma
Q36142004Quantitative proteome analysis of colorectal cancer-related differential proteins
Q35606645Quantitative proteomic analysis reveals that anti-cancer effects of selenium-binding protein 1 in vivo are associated with metabolic pathways
Q34737626Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium
Q54434422Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma.
Q38201580Selenium and selenoproteins in inflammatory bowel diseases and experimental colitis
Q40428099Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer
Q59792718Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes
Q37249829Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome
Q51740537Selenium-binding protein 1 is down-regulated in malignant melanoma.
Q92523385Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer
Q28535416The function and significance of SELENBP1 downregulation in human bronchial epithelial carcinogenic process
Q36945715Toward understanding success and failures in the use of selenium for cancer prevention
Q30896473Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts